Cardiol Therapeutics Inc.: Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences
Cardiol Therapeutics Inc. (
Cardiol or the
Company ), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, announced today that David Elsley, President and CEO of Cardiol, will participate in the following upcoming virtual investor conferences:
10th Annual LifeSci Partners Corporate Access Event - January 6-8 and 11-14, 2021. Mr. Elsley will present, participate in a panel discussion
Developing Drugs for Cardiovascular Indications , and hold one-on-one investor meetings.
H.C. Wainwright Bioconnect 2021 Conference - January 11-14, 2021. Mr. Elsley will give a presentation which will also be available for viewing on Cardiol s website.